Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcomeYi‐Jun Xue, Haiwen Huang|Journal of Experimental & Clinical Cancer Research|2019Cited by 27
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 TrialYuqin Song, Xin Du, Yue-Rong Shuang et al.|Advances in Therapy|2021Cited by 19
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label studyLijuan Deng, Jun Zhu, Zhiming Li et al.|American Journal of Hematology|2023Cited by 18
Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expressionMingzhong Rui, Haiwen Huang|Molecular Medicine Reports|2014Cited by 13
Role of epithelial-to-mesenchymal transition in the pulmonary fibrosis induced by paraquat in ratsYi Jianhua, Yuwen Huang, Zhaocai Zhang et al.|World Journal of Emergency Medicine|2021Cited by 7